Utrogestan 300 mg Norge - norska - Statens legemiddelverk

utrogestan 300 mg

besins healthcare ireland limited (1) - progesteron - vaginalkapsel, myk - 300 mg

Tibsovo Europeiska unionen - norska - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Orserdu Europeiska unionen - norska - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Instanyl 100 mikrog/ dose Norge - norska - Statens legemiddelverk

instanyl 100 mikrog/ dose

orifarm as - fentanyl - nesespray, oppløsning - 100 mikrog/ dose

Instanyl 200 mikrog/ dose Norge - norska - Statens legemiddelverk

instanyl 200 mikrog/ dose

orifarm as - fentanyl - nesespray, oppløsning - 200 mikrog/ dose

Bosulif 400 mg Norge - norska - Statens legemiddelverk

bosulif 400 mg

abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg

Bosulif 100 mg Norge - norska - Statens legemiddelverk

bosulif 100 mg

2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg